Skip to content

Reinforcement of Upper Airway Muscles in Patients With OSAS

Non-invasive Reinforcement of the Upper Airway Dilator Muscles as an Alternative Approach to Treat Patients With Obstructive Sleep Apnea

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03846349
Enrollment
36
Registered
2019-02-19
Start date
2019-08-01
Completion date
2020-07-01
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Syndrome

Brief summary

This study will investigate the effectiveness of a simple and quick myofunctional reeducation protocol of the tongue in reducing the obstructive sleep apnea syndrome (OSAS) severity.

Detailed description

This is a randomized controlled study. Participants with moderate OSAS severity will be either allocated to receive a myofunctional reeducation protocol (study group) or a sham protocol (control group). Apnea-hypopnea index (AHI) will be measured before and at the end (6 weeks) of the protocol. Participants from the study group will follow an upper airway reinforcement regimen using the IOPI (Iowa Oral Performance Instrument) device over 6 weeks while participants from the control group will perform a sham reeducation protocol using an EMT threshold at minimal resistance.

Interventions

DEVICEIOPI

IOPI is a portable device with a tongue bulb used to reinforce upper airway muscles.

DEVICEEMT threshold

EMT threshold is a small portable device producing a positive expiratory pressure when the patient is exhaling.

Sponsors

Haute Ecole de Santé Vaud
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Moderate obstructive sleep apnea syndrome (AHI between 15 and 30 events per hour) * Poor adherence to continuous positive airway pressure (\< 4h per night)

Exclusion criteria

* Craniofacial malformation * Use of hypnotic medication * Had stroke in the past * Present a concurrent neuromuscular or severe obstructive nasal disease

Design outcomes

Primary

MeasureTime frameDescription
Change in AHI (apnea-hypopnea index) on polygraphyBaseline and 6 weeksEvolution of the number of apnea-hypopnea events (AHI) over 6 weeks. The AHI value at discharge will be compared with the baseline value.

Secondary

MeasureTime frameDescription
Change in tongue strength using the IOPI deviceBaseline and 6 weeksEvolution of tongue strength over 6 weeks. Tongue strength will be measured by asking the participants to squeeze the tongue bulb of IOPI as much as possible over 3 seconds. Three trials are accepted and the best value will be recorded (Pmax). Pmax at discharge will be compared with Pmax at baseline.
Change in tongue endurance using the IOPI deviceBaseline and 6 weeksEvolution of tongue endurance over 6 weeks. Tongue endurance will be measured by asking the participants to sustain a tongue pressure against the IOPI bulb at 50% of Pmax. Endurance will be assessed by measuring the holding duration of 50% of Pmax. Holding duration at discharge will be compared with the value at baseline.

Countries

Switzerland

Contacts

Primary ContactOlivier Contal, PhD
olivier.contal@hesav.ch+41213168122
Backup ContactWilliam Poncin, PhD
william.poncin@uclouvain.be

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026